Ozempic unlocked mass market adoption by reducing injections from twice daily (liraglutide) to once weekly while doubling the therapeutic effect.
Snapshot · God Mode Podcast
Ozempic unlocked mass market adoption by reducing injections from twice daily (liraglutide) to once weekly while doubling the therapeutic effect.
Where this was said
At 55:35 · chapter starts 51:50
Retatrutide Phase 3 trials showed 28.3% body weight loss on 12mg over 80 weeks, significantly outperforming earlier GLP-1 drugs.
Ozempic triggered a revolution by cutting injections from twice daily to once weekly. Retatrutide adds a third receptor key — GLP-1, GIP, and glucagon — delivering 28.3% body weight loss in Phase 3 trials. Think of each generation as a Pokemon evolution, and we're not close to the final form.
Natural GLP-1 has a half-life of only 30 minutes in the blood; drug engineers have extended this to enable weekly injections with sustained effect.
Taking a drug from early research to market approval costs an average of $2.3 billion and takes a median of 15 years.
Brand-name Ozempic costs around $400 per month in the US, while equivalent peptides sourced from China cost $10–20, a 20-40x price gap.
Developing a drug costs $2.3 billion over 15 years. You get 8 years to recoup it before generics hit. Meanwhile, US compounding pharmacies exploit a loophole to sell unbranded Ozempic for $50 instead of $1,500. It's the AI subscription pricing model applied to pharmaceuticals.
Despite predictions that AI would eliminate radiologists, the Mayo Clinic's radiology staff grew 55% after AI arrived at reading scans.
In 2025, radiology was the second-highest paid medical specialty in America, with average incomes 48% higher than a decade ago.
A study across 3 hospitals found radiologists spent only 36% of their time reading scans — the part AI can do — with the rest being human judgment.
Robert Greene notes that one in six Americans is on some form of drug to deal with depression, suggesting a deep societal disconnection from meaningful experience.
Spencer Greenberg and Jeremy Stevenson analyzed almost 500 self-improvement techniques and found they all reduce to just 12 underlying psychological drivers.
Cold exposure has good short-term alertness benefits but the evidence base for long-term health benefits is much weaker than popularly believed.
In a randomized study of 20 habit-formation techniques run on hundreds of people, almost none of the techniques produced statistically meaningful results.
People given a tiny-habit fallback option (e.g. 10 squats instead of gym) were actually MORE successful at completing the full habit, not less.
The most effective habit-formation technique was 'habit reflection' — recalling a past successful habit, writing down what helped, then applying those lessons to a new habit.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.